Serological procedures useful for the detection of rheumatoid factors, utilizing polystyrene latex particles, have become well established and show a reasonably good degree of specificity and sensitivity (Mayne and Mathieson, 1961; Plotz and Singer, 1956; Vaughan, 1959) . The use of these tests has been reviewed by Singer (1961) and Waller, Decker, Toone, and Irby (1961) . The tests have also been found of value in studying patients with nonrheumatic diseases (Atwater and Jacox, 1963; Caplan, 1963; Dresner and Trombly, 1959; Howell, Malcolm, and Pike, 1960) . Many modifications of the original Singer and Plotz Fraction II Latex Particle (F-IT L.P.) method (Singer and Plotz, 1956) have been reported, both slide and test tube (Bird and Burr, 1962; Rheins, McCoy, Buehler, and Burrell, 1957a; Singer and Plotz, 1958a, b) . The F-TI L.P. procedure uses polystyrene latex particles (Dow, 0 81 ,t in diameter) sensitized with human gamma globulin (Fraction TI) in an alkaline buffer. Rheins, McCoy, Burrell, and Buehler (1957b) showed that gamma globulin from seven animal species, including bovine, could be used in place of human gamma globulin. Burby and Behr (1958) found that Dow 0 81 , particles sensitized with bovine globulin were as satisfactory for this test as were those sensitized with human gamma globulin, and the same authors (1959) also reported that a new polystyrene latex particle manufactured in Great Britain gave results equivalent to those obtained with the Dow particles, if used in a different dilution. Payne (1961) described a new procedure using the British latex particles sensitized with bovine gamma globulin in an alkaline buffer. He claimed that his procedure showed good agreement with the sensitized sheep cell agglutination test (Jacobson, Kammerer, Wolf, Epstein, and Heller, 1956 ) and F-TI L.P. tests, and was technically simpler.
Recently, we have prepared a new preserved concentrated antigen for the detection of rheumatoid factor in serum. This antigent is prepared from polystyrene latex particles, similar to those used by Payne (1961) (2) Eosin latex slide test (Singer and Plotz, 1958b) using 1 per cent. and 2 per cent. eosin. Agglutination in either dilution of eosin was considered positive.
(3) F-Il L.P. using human gamma globulin and Dow 0-81 u particles (Singer and Plotz, 1956 ). 
Comparative results between these two tests are shown in Table IL . (Table I) , thus confirming the observations of Lane and Decker (1960) , Caplan (1960 Caplan ( , 1963 , and Bianchi and Keech (1963) .
A comparison of the titres obtained with the two latex tests is shown in Table III (opposite); the titres are uniformly higher with the F-II L.P. than with the preserved antigen. This numerical difference in titre, of course, offers no advantage as long as the same technique is adhered to throughout.
Stability studies on the preserved antigen were done by taking aliquots of positive sera and storing them in the deep freeze. The titres of the serum were then determined at intervals with the same lot of antigen stored in the refrigerator for 9 months. The stability of the preserved antigen was quite satisfactory (Table IV, A-2  80  80  80  40  80  80  80   A-3  40  40  40  40  80  40  40   3  A-1  160  160  160  160  160  80  160  A-2  160  160  160  160  160  320  160  A-3  160  160  160  80  160  160  160   4  A-I  640  640  640  640  640  640  640  A-2  640  640  320  640  640  640  640  A-3  640  640  640  640  640  640 The use of the new preserved antigen seems to offer the following advantages:
(1) No zoning effect was encountered, contrary to the F-1I L.P. (Schubart, Cohen, and Calkins, 1959 (Atwater and Jacox, 1963; Caplan, 1960; Caplan, 1963; Bianchi and Keech, 1963) . Few positive reactions were found in this series in non-rheumatic diseases.
Summary Experience with a new concentrated preserved latex antigen for use in quantitative testing for rheumatoid factor is described. A comparison of the new antigen with two widely-used slide tests and the F II latex tube test shows it to be satisfactorily specific and sensitive. The advantages of this new antigen are discussed. 
